SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
729Press Release Source: Celgene Corporation REVLIMID(R) Granted Full Marketing Ausim1-6/19/2007
728Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to sim1-5/22/2007
727Celgene Stock Rises Amid Drug Trial Data Speculation Tue Apr 3, 2007 10:03 PM BSsim1-4/4/2007
726Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiplesim1-3/23/2007
725Merrill sticks to its guns: Company Updates Celgene Corporation (CELG, US$54.64tom pope-3/22/2007
724ML Conference Highlights Celgene’s commercial and research efforts on all cylintom pope-2/7/2007
723Cancer Drug Helps Celgene Shares>CELG 2:02 PM EST January 19, 2007 By Petersim1-1/19/2007
722More Merrill: Pre-announces in-line ‘06 revenue, gives ‘07 outlook Celgene pre-tom pope-1/9/2007
721Merrill, bullish write up: Raising price objective to $73 with rapid growth exptom pope-1/8/2007
720Historically Barr is VERY good with patent challenges, winning and settling far rkrw-12/14/2006
719CITI's Take on the Barr / Generic Thalomid filing (From one of the residentsim1-12/14/2006
718Tuck, do not know answer on almost your entire questions. Celgene did develop &qMiljenko Zuanic-12/14/2006
717>>Didn't Bar licensed STEPS distribution patents for other candidate?&tuck-12/14/2006
716Didn't Bar licensed STEPS distribution patents for other candidate? My thouMiljenko Zuanic-12/13/2006
715I believe the only i.p. is the Celgene STEPS distribution program. I was always rkrw-12/13/2006
714>>Celgene Notified of ANDA Filing for Thalidomide Wednesday December 13, 9tuck-12/13/2006
713Merrill: Celgene updates expansion plans for Revlimid at ASH Celgene sketched otom pope-12/11/2006
712Once-feared drug is Celgene's winner Stock is up 67% this year on drug thasim1-12/7/2006
711They should distribute to charities that deal with AIDS.Miljenko Zuanic-11/5/2006
710That's a big chunk of change. Any idea what they'll do with it?technetium-11/5/2006
709Now, they can go "shopping"! Celgene Announces Pricing of Common StocMiljenko Zuanic-11/3/2006
708Celgene Intends to Issue Up to Approximately 20 Million Shares of Common Stock isim1-11/1/2006
707leprosy was only excuse. HIV black market forced FDA to "legalize" ThMiljenko Zuanic-10/30/2006
706Started with leprosy approval! Analysts dumped on it, no potential. Very hard torkrw-10/30/2006
705In bio-sector, best performing stock ever. 100X in last 10 years, GILD is 30X, AMiljenko Zuanic-10/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News